+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemotherapy Agent"

Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • September 2022
  • 239 Pages
  • Global
From
Masitinib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Masitinib Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Chemotherapy Induced Nausea And Vomiting Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Chemotherapy Induced Nausea And Vomiting Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Chemotherapy Induced Neutropenia Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Chemotherapy Induced Neutropenia Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Bispecific Antibodies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Bispecific Antibodies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • December 2021
  • 99 Pages
  • Global
From
Cancer Supportive Care Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Cancer Supportive Care Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • October 2021
  • 112 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019-2027 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019-2027

  • Report
  • August 2019
  • Global
From
Cancer Cachexia Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Cachexia Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
FYARRO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

FYARRO Market Size, Forecast, and Market Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 245 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 280 Pages
  • Global
From
Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Chemotherapy-induced Peripheral Neuropathy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Chemotherapy-induced Peripheral Neuropathy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • June 2023
  • 159 Pages
  • Global
From
Chemotherapy-induced Peripheral Neuropathy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy-induced Peripheral Neuropathy - Epidemiology Forecast - 2032

  • Report
  • June 2023
  • 80 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Loading Indicator

The Chemotherapy Agent market within the Healthcare Services sector is a rapidly growing industry. It is composed of a variety of products and services that are used to treat cancer and other diseases. These products and services include drugs, medical devices, and other treatments. The market is driven by the increasing prevalence of cancer and other diseases, as well as the development of new treatments and technologies. The Chemotherapy Agent market is highly competitive, with many companies offering a wide range of products and services. Companies in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Roche. These companies are constantly innovating and developing new products and services to meet the needs of patients and healthcare providers. Show Less Read more